Market Overview The Keytruda market is experiencing indication expansion emphasis where clinical trials, emerging cancer indications, and treatment combination enable broadened applications. The Keytruda market is projected to exceed USD 32.8 billion through 2030, with expansion emphasis driven by trial success, new indication pursuit, and combination strategies. Indication expansion represents...